| Literature DB >> 33668878 |
Makram Merimi1,2, Philippe Lewalle1, Nathalie Meuleman1, Douâa Moussa Agha1, Hoda El-Kehdy3, Fatima Bouhtit1,2, Sara Ayoub4, Arsène Burny5, Hassan Fahmi6, Laurence Lagneaux7, Mehdi Najar6,7.
Abstract
Mesenchymal stem/stromal cells (MSCs) are considered a relevant therapeutic product for various clinical applications [...].Entities:
Year: 2021 PMID: 33668878 DOI: 10.3390/jcm10050905
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241